Brief: Oncopeptides Presents New Data Highlighting Treatment Benefits Of Pepaxti

Oncopeptides AB

16/05/2024 08:20

May 16 (Reuters) - Oncopeptides AB  ONCO.ST :
    * ONCOPEPTIDES PRESENTS NEW DATA HIGHLIGHTING TREATMENT
BENEFITS
OF PEPAXTI IN HIGH-RISK MULTIPLE MYELOMA PATIENTS AT THE COMY
CONGRESS
    * RESEARCH FINDINGS INDICATE THAT MELFLUFEN IS MORE
EFFECTIVE THAN
TRADITIONAL ALKYLATING AGENTS CAUSING DNA DAMAGE
    * STUDY ALSO SIGNIFICANT CHANGES IN GENE EXPRESSION THAT
ENHANCE
DRUG'S IMPACT ON CANCER CELLS

Source text for Eikon:  ID:nMFNcdnwlH 
Further company coverage:  ONCO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))